MTOR and breast carcinoma: The mammalian target of rapamycin (mTOR), another protein with key functions in cell growth and proliferation, for example, is able to regulate p73, and treatment with rapamycin sensitizes highly aggressive breast cancer cells to cisplatin through upregulation of TAp73 [55-57].